Teladoc (TDOC) Stock Forecast & Price Target

Compare

12,031 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TDOC Analyst Ratings

Hold

2 Buy

10 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Teladoc

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TDOC Stock 12 Month Forecast

Average Price Target

$9.06

▲(26.01% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Teladoc in the last 3 months. The average price target is $9.06 with a high forecast of $12.00 and a low forecast of $7.50. The average price target represents a 26.01% change from the last price of $7.19.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","7":"$7","9":"$9","11":"$11","13":"$13"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.06,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.06</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,7,9,11,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.94,7.32923076923077,7.718461538461539,8.107692307692307,8.496923076923077,8.886153846153846,9.275384615384615,9.664615384615384,10.053846153846154,10.443076923076923,10.832307692307692,11.221538461538461,11.61076923076923,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.94,7.103076923076923,7.266153846153847,7.429230769230769,7.592307692307693,7.7553846153846155,7.918461538461539,8.081538461538463,8.244615384615384,8.407692307692308,8.570769230769232,8.733846153846155,8.896923076923077,{"y":9.06,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.94,6.983076923076924,7.026153846153846,7.06923076923077,7.112307692307692,7.155384615384616,7.1984615384615385,7.241538461538462,7.2846153846153845,7.327692307692308,7.3707692307692305,7.413846153846154,7.456923076923077,{"y":7.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.59,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.17,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.86,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.21,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.5,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.09,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.16,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.56,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 35, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.99,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.87,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.58,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.94,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$12.00

Average Price Target$9.06

Lowest Price Target$7.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Allen Lutz

Bank of America Securities

$8.5

Hold

18.22%

Upside

Reiterated

08/21/25

Teladoc's Mixed Performance and Growth Challenges Lead to Hold RatingWe also note that Teladoc is progressing on rolling out insurance capabilities and in late June, soft launched BetterHelp insurance in a single state. We look for continued progress on the integration of UpLift and potential changes to patient engagement over the next few quarters. We maintain our Neutral rating on Teladoc and $8.50 PO as Teladoc balances execution from growth initiatives and investments for future growth. We roll forward our multiple to 5.0x CY26E EBITDA from 6.0x CY25E prior.

Jailendra Singh

Truist Financial

―

Hold

―

Reiterated

08/05/25

Teladoc (TDOC) Gets a Hold from Truist Financial

David Grossman

Stifel Nicolaus

Hold

11.27%

Upside

Reiterated

07/30/25

Stifel Nicolaus Sticks to Its Hold Rating for Teladoc (TDOC)

Ryan MacDonald

Needham

―

Hold

―

Reiterated

07/30/25

Cautious Hold on Teladoc Amid Competitive Pressures and Strategic Risks

Michael Cherny

Leerink Partners

$7.5

Hold

4.31%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures

Charles Rhyee

TD Cowen

Hold

11.27%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Strong IC Growth Overshadowed by BH Segment Uncertainty Leading to Hold Rating

Elizabeth Anderson CFA

Evercore ISI

$7→$8

Hold

11.27%

Upside

Reiterated

07/30/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC), Ionis Pharmaceuticals (NASDAQ: IONS) and Repligen (NASDAQ: RGEN)

Sarah James

Cantor Fitzgerald

$12→$10

Buy

39.08%

Upside

Reiterated

07/29/25

Teladoc price target lowered to $10 from $12 at Cantor FitzgeraldTeladoc price target lowered to $10 from $12 at Cantor Fitzgerald

Ryan Daniels

William Blair

―

Hold

―

Reiterated

07/29/25

Teladoc's Transitional Phase: Balancing Growth Challenges and Strategic Opportunities

Daniel Grosslight

Citi

$8→$9.5

Hold

32.13%

Upside

Reiterated

07/28/25

Citi Keeps Their Hold Rating on Teladoc (TDOC)

Steven Valiquette

Mizuho Securities

$10

Hold

39.08%

Upside

Initiated

07/25/25

Teladoc's Mixed Prospects: Hold Rating Amid Growth in Integrated Care and Challenges in BetterHelp Segment

Jessica Tassan

Piper Sandler

$12

Buy

66.90%

Upside

Reiterated

07/18/25

Teladoc (TDOC) Receives a Buy from Piper Sandler

Lisa Gill

J.P. Morgan

$11→$9

Hold

25.17%

Upside

Reiterated

05/16/25

Teladoc (TDOC) PT Lowered to $9 at JPMorganJPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $9.00 (from $11.00) while maintaining a Neutral rating.

Stephen Baxter

Wells Fargo

$10→$8

Hold

11.27%

Upside

Reiterated

05/08/25

Teladoc (TDOC) PT Lowered to $8 at Wells FargoWells Fargo analyst Stephen Baxter lowered the price target on Teladoc (NYSE: TDOC) to $8.00 (from $10.00) while maintaining a Equal Weight rating.

Vikram Kesavabhotla

Robert W. Baird

$9→$7

Hold

-2.64%

Downside

Reiterated

05/06/25

Teladoc (TDOC) PT Lowered to $7 at BairdBaird analyst Vikram Kesavabhotla lowered the price target on Teladoc (NYSE: TDOC) to $7.00 (from $9.00) while maintaining a Neutral rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Allen Lutz

Bank of America Securities

$8.5

Hold

18.22%

Upside

Reiterated

08/21/25

Jailendra Singh

Truist Financial

―

Hold

―

Reiterated

08/05/25

Teladoc (TDOC) Gets a Hold from Truist Financial

David Grossman

Stifel Nicolaus

Hold

11.27%

Upside

Reiterated

07/30/25

Stifel Nicolaus Sticks to Its Hold Rating for Teladoc (TDOC)

Ryan MacDonald

Needham

―

Hold

―

Reiterated

07/30/25

Cautious Hold on Teladoc Amid Competitive Pressures and Strategic Risks

Michael Cherny

Leerink Partners

$7.5

Hold

4.31%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Solid Integrated Care Growth Amid BetterHelp Challenges and Macroeconomic Pressures

Charles Rhyee

TD Cowen

Hold

11.27%

Upside

Reiterated

07/30/25

Teladoc's Mixed Performance: Strong IC Growth Overshadowed by BH Segment Uncertainty Leading to Hold Rating

Elizabeth Anderson CFA

Evercore ISI

$7→$8

Hold

11.27%

Upside

Reiterated

07/30/25

Analysts' Opinions Are Mixed on These Healthcare Stocks: Teladoc (NYSE: TDOC), Ionis Pharmaceuticals (NASDAQ: IONS) and Repligen (NASDAQ: RGEN)

Sarah James

Cantor Fitzgerald

$12→$10

Buy

39.08%

Upside

Reiterated

07/29/25

Teladoc price target lowered to $10 from $12 at Cantor FitzgeraldTeladoc price target lowered to $10 from $12 at Cantor Fitzgerald

Ryan Daniels

William Blair

―

Hold

―

Reiterated

07/29/25

Teladoc's Transitional Phase: Balancing Growth Challenges and Strategic Opportunities

Daniel Grosslight

Citi

$8→$9.5

Hold

32.13%

Upside

Reiterated

07/28/25

Citi Keeps Their Hold Rating on Teladoc (TDOC)

Steven Valiquette

Mizuho Securities

$10

Hold

39.08%

Upside

Initiated

07/25/25

Teladoc's Mixed Prospects: Hold Rating Amid Growth in Integrated Care and Challenges in BetterHelp Segment

Jessica Tassan

Piper Sandler

$12

Buy

66.90%

Upside

Reiterated

07/18/25

Teladoc (TDOC) Receives a Buy from Piper Sandler

Lisa Gill

J.P. Morgan

$11→$9

Hold

25.17%

Upside

Reiterated

05/16/25

Teladoc (TDOC) PT Lowered to $9 at JPMorganJPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $9.00 (from $11.00) while maintaining a Neutral rating.

Stephen Baxter

Wells Fargo

$10→$8

Hold

11.27%

Upside

Reiterated

05/08/25

Teladoc (TDOC) PT Lowered to $8 at Wells FargoWells Fargo analyst Stephen Baxter lowered the price target on Teladoc (NYSE: TDOC) to $8.00 (from $10.00) while maintaining a Equal Weight rating.

Vikram Kesavabhotla

Robert W. Baird

$9→$7

Hold

-2.64%

Downside

Reiterated

05/06/25

Teladoc (TDOC) PT Lowered to $7 at BairdBaird analyst Vikram Kesavabhotla lowered the price target on Teladoc (NYSE: TDOC) to $7.00 (from $9.00) while maintaining a Neutral rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Teladoc

1 Month

xxx

Success Rate

19/42 ratings generated profit

Average Return

-3.19%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 45.24% of your transactions generating a profit, with an average return of -3.19% per trade.

3 Months

xxx

Success Rate

26/48 ratings generated profit

Average Return

+2.01%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 54.17% of your transactions generating a profit, with an average return of +2.01% per trade.

1 Year

Richard CloseCanaccord Genuity

Success Rate

24/48 ratings generated profit

Average Return

+17.29%

reiterated a buy rating 4 months ago

Copying Richard Close's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +17.29% per trade.

2 Years

xxx

Success Rate

21/48 ratings generated profit

Average Return

+46.01%

reiterated a xxx

rating 4 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 43.75% of your transactions generating a profit, with an average return of +46.01% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TDOC Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TDOC has received 2 Buy Ratings, 27 Hold Ratings, and 0 Sell Ratings. TDOC average Analyst price target in the past 3 months is 9.06.

Each month's total comprises the sum of three months' worth of ratings.

TDOC Financial Forecast

TDOC Earnings Forecast

Next quarter’s earnings estimate for TDOC is -$0.26 with a range of -$0.34 to -$0.17. The previous quarter’s EPS was -$0.19. TDOC beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.06% of the time in the same period. In the last calendar year TDOC has Outperformed its overall industry.

TDOC Sales Forecast

Next quarter’s sales forecast for TDOC is $625.90M with a range of $620.00M to $631.90M. The previous quarter’s sales results were $631.90M. TDOC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.27% of the time in the same period. In the last calendar year TDOC has Outperformed its overall industry.

TDOC Stock Forecast FAQ

What is TDOC’s average 12-month price target, according to analysts?

Based on analyst ratings, Teladoc’s 12-month average price target is 9.06.

What is TDOC’s upside potential, based on the analysts’ average price target?

Teladoc has 26.01% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TDOC a Buy, Sell or Hold?

Teladoc has a consensus rating of Hold which is based on 2 buy ratings, 10 hold ratings and 0 sell ratings.

What is Teladoc’s price target?

The average price target for Teladoc is 9.06. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $7.50. The average price target represents 26.01% Increase from the current price of $7.19.

What do analysts say about Teladoc?

Teladoc’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of TDOC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Teladoc (TDOC) Stock Forecast & Price Target

TDOC Analyst Ratings

TDOC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Teladoc

TDOC Analyst Recommendation Trends

TDOC Financial Forecast

TDOC Earnings Forecast

TDOC Sales Forecast

TDOC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts